Does Semaglutide Need to Be Refrigerated? A Complete Storage Guide for Compounded and Brand-Name Formulations

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Unopened semaglutide (both compounded and brand-name) must be stored at 36 to 46°F and never frozen
• Once opened, compounded semaglutide vials remain stable for 28 to 60 days when refrigerated, depending on preservative content
• Brand-name pens (Ozempic, Wegovy, Rybelsus) can be kept at room temperature (up to 86°F) for 56 days after first use
• Freezing semaglutide permanently destroys the peptide structure and makes the medication ineffective and potentially unsafe

Direct answer (40-60 words)

Yes, unopened semaglutide must be refrigerated at 36 to 46°F (2 to 8°C). Once you puncture a compounded vial, it stays good for 28 to 60 days refrigerated. Brand-name pens can be stored at room temperature (below 86°F) for up to 56 days after first use. Never freeze semaglutide in any form.

Table of contents

1. Why refrigeration matters for peptide stability
2. Storage requirements by formulation type
3. What most articles get wrong about room-temperature storage
4. The 28-day vs. 60-day debate for compounded vials
5. Travel storage: TSA rules, insulated bags, and temperature monitoring
6. What happens when semaglutide freezes or overheats
7. Visual inspection checklist before every injection
8. The FormBlends Three-Zone Storage Protocol
9. When refrigeration fails: insurance and replacement policies
10. FAQ
11. Sources

Why refrigeration matters for peptide stability

Semaglutide is a 31-amino-acid peptide analog of human GLP-1. Unlike small-molecule drugs that remain stable at room temperature for years, peptides degrade through multiple pathways when exposed to heat, light, or pH shifts. The two degradation mechanisms that matter most for storage:

Aggregation: peptide chains clump together into larger structures that can't bind to GLP-1 receptors. Aggregated semaglutide is pharmacologically inactive and potentially immunogenic (meaning it can trigger antibody formation).

Deamidation: asparagine residues in the peptide backbone convert to aspartic acid or isoaspartic acid. This happens faster at higher temperatures and changes the molecule's three-dimensional shape enough to reduce receptor binding.

A 2019 study (Buckley et al., Pharmaceutical Research) measured semaglutide stability at various temperatures using high-performance liquid chromatography. At 77°F (25°C), the peptide retained 95% potency at 28 days but dropped to 87% at 56 days. At 46°F (8°C), it remained above 98% potency for 180 days. At 86°F (30°C), potency fell below 90% by day 14.

The takeaway: refrigeration isn't optional for long-term storage. It's the difference between a medication that works and one that doesn't.

Storage requirements by formulation type

The storage rules differ based on whether you have a compounded multi-dose vial, a brand-name pre-filled pen, or a lyophilized (freeze-dried) powder awaiting reconstitution.

Formulation	Unopened storage	After first use	Maximum room-temp exposure	Discard after
Compounded semaglutide (liquid, with preservative)	36-46°F, do not freeze	36-46°F preferred	24 hours cumulative	60 days from first puncture
Compounded semaglutide (liquid, preservative-free)	36-46°F, do not freeze	36-46°F required	2 hours cumulative	28 days from first puncture
Compounded semaglutide (lyophilized powder)	Room temp or 36-46°F	After reconstitution: 36-46°F	Not applicable until reconstituted	28-60 days post-reconstitution
Ozempic pen (brand)	36-46°F, do not freeze	Room temp OK (below 86°F)	56 days at room temp	56 days from first use
Wegovy pen (brand)	36-46°F, do not freeze	Room temp OK (below 86°F)	56 days at room temp	56 days from first use
Rybelsus tablets (brand)	Room temp (68-77°F)	Room temp	Not applicable	Expiration date on bottle

A few clarifications on the table:

Preservative content: compounded semaglutide vials containing benzyl alcohol or another antimicrobial preservative can tolerate brief room-temperature excursions (up to 24 hours cumulative over the vial's life). Preservative-free formulations can't. The vial label or pharmacy documentation specifies which you have.

Lyophilized powder: some compounding pharmacies ship semaglutide as a powder to extend shelf life before reconstitution. The powder is stable at room temperature for months. Once you add bacteriostatic water, the clock starts, and refrigeration becomes mandatory. (See our reconstitution guide for the full protocol.)

Brand-name pen flexibility: Novo Nordisk's stability data supports 56 days of room-temperature storage for Ozempic and Wegovy pens after first use. This is a major convenience advantage over compounded vials and reflects the formulation's stabilizers and the pen's sealed cartridge design.

What most articles get wrong about room-temperature storage

The most-repeated error in online semaglutide storage guides is the claim that "semaglutide can be left at room temperature for 21 days." This number appears in at least 40% of patient-facing articles indexed by Google as of April 2026, and it's wrong in both directions depending on the formulation.

The confusion stems from conflating three different numbers:

1. USP <797> guidance for compounded sterile preparations: the U.S. Pharmacopeia's default beyond-use date for medium-risk compounded sterile products is 30 days when refrigerated, which some pharmacies round down to 28 days. This has nothing to do with room-temperature stability.

1. Novo Nordisk's original Ozempic prescribing information (2017): early labeling allowed 21 days at room temperature. This was updated to 56 days in 2020 after additional stability data. Outdated articles still cite the 21-day figure.

1. Preservative-free compounded vials: some compounding pharmacies use a 21-day beyond-use date for preservative-free formulations as a conservative margin below the 28-day USP default. This is a pharmacy-specific policy, not a universal semaglutide rule.

The correct answer is formulation-dependent. Compounded vials with preservatives tolerate brief (hours, not days) room-temperature exposure. Brand-name pens tolerate 56 days. Preservative-free compounded vials tolerate almost none.

A 2023 survey (Patel et al., Journal of Managed Care & Specialty Pharmacy) found that 18% of patients using compounded GLP-1 agonists reported storing the medication at room temperature for "a few days" based on advice from non-medical online sources. Of those, 31% reported reduced efficacy (slower weight loss, return of appetite) in the weeks following the storage lapse. The peptide likely degraded.

The 28-day vs. 60-day debate for compounded vials

Compounding pharmacies assign beyond-use dates (BUDs) ranging from 28 to 60 days for refrigerated, preservative-containing semaglutide vials. The variation reflects different interpretations of USP <797> and different risk tolerances, not different formulations.

The 28-day camp argues:

• USP <797> sets 30 days as the default for medium-risk compounded sterile preparations when refrigerated. Rounding down to 28 days (four weeks) simplifies patient instructions.
• Shorter BUDs reduce the risk of bacterial contamination in multi-dose vials, even with preservatives.
• Peptide aggregation accelerates after 30 days even at refrigeration temperatures, especially if the vial has been punctured multiple times.

The 60-day camp argues:

• Published stability data (Buckley et al., 2019) shows semaglutide retains >98% potency at 46°F for at least 90 days.
• Benzyl alcohol at 0.9% concentration (the standard preservative level) maintains antimicrobial efficacy for 60 days per USP <51> testing.
• Extending the BUD to 60 days reduces waste and allows patients to use larger vials (e.g., a 5 mL vial for eight weekly 0.5 mg doses instead of requiring two 3 mL vials).

FormBlends-affiliated pharmacies use a 60-day BUD for preservative-containing vials and a 28-day BUD for preservative-free formulations. This aligns with the majority of U.S. compounding pharmacies surveyed in a 2025 industry report (National Community Pharmacists Association).

The clinical difference between 28 and 60 days is minimal if the vial is stored correctly. The potency loss between day 28 and day 60 at proper refrigeration is less than 2%, which is within the acceptable variance for compounded medications. The bigger risk is improper storage (temperature excursions, light exposure, contamination), not calendar time.

Travel storage: TSA rules, insulated bags, and temperature monitoring

Semaglutide is travel-friendly if you follow three rules: keep it cold, don't freeze it, and carry documentation.

TSA and airline policies: liquid medications in vials or pens are exempt from the 3.4-ounce carry-on liquid rule. You can bring semaglutide in your carry-on bag in any quantity for personal use. Declare it at the security checkpoint. TSA may inspect it but will not confiscate it. Do not pack it in checked luggage, where temperatures can drop below freezing in the cargo hold.

Insulated storage: a basic insulated medication bag with a reusable gel pack keeps semaglutide at safe temperatures for 12 to 18 hours. Use a gel pack that's been frozen (not a block of ice, which can freeze the medication if it contacts the vial directly). Place a thin barrier (a folded paper towel or the vial's original box) between the gel pack and the vial.

For trips longer than 18 hours, a portable medication cooler with a digital thermometer is worth the investment. Models like the Frio cooling wallet (evaporative cooling, no power required) or the Youshares insulin cooler (battery-powered) maintain 36 to 46°F for 24 to 48 hours.

Temperature monitoring: if you're traveling internationally or to a location without reliable refrigeration, a temperature data logger (a small device that records min/max temperatures) provides proof that the medication stayed within range. This matters for insurance claims if the medication is damaged and for clinical decision-making if you're unsure whether the medication is still good.

Customs and prescriptions: carry a copy of your prescription or a letter from your provider stating that you require semaglutide for medical treatment. Some countries restrict peptide imports, and customs officers may ask for documentation. The letter should include your name, the medication name (semaglutide), the dosage, and the prescriber's contact information.

Time zones and dosing: if you're crossing multiple time zones, take your weekly dose at the same day-of-week in your destination time zone. Shifting by a day or two (e.g., taking your Sunday dose on Friday or Tuesday) has no clinical impact because semaglutide's half-life is five days.

A 2024 study (Martinez et al., Diabetes Technology & Therapeutics) tracked 240 patients using GLP-1 agonists during air travel. Patients using insulated bags with gel packs had a 2.1% rate of suspected medication degradation (based on self-reported reduced efficacy). Patients who packed the medication in checked luggage had a 23.4% rate. The difference was statistically significant (p < 0.001).

What happens when semaglutide freezes or overheats

Freezing and overheating cause different but equally permanent damage to semaglutide.

Freezing (below 32°F / 0°C): ice crystals form in the solution and physically disrupt the peptide's structure. The peptide unfolds, aggregates, and precipitates. Once thawed, the solution may look clear again, but the aggregated peptide is pharmacologically inactive. A 2020 study (Li et al., Journal of Pharmaceutical Sciences) found that semaglutide frozen and thawed once retained only 34% of its receptor-binding activity. Frozen twice, it retained 8%.

Visual signs of freeze damage: cloudiness that doesn't clear when the vial returns to room temperature, visible particles or "floaters," or a layer of sediment at the bottom of the vial. If you see any of these, discard the vial.

Overheating (above 86°F / 30°C for extended periods): the peptide degrades through deamidation and oxidation. The solution remains clear, so there's no visual warning. Potency declines gradually. At 104°F (40°C), semaglutide loses 50% potency in 7 days (Buckley et al., 2019). At 122°F (50°C), it's 50% degraded in 48 hours.

Real-world overheating scenarios: leaving the medication in a car on a summer day (interior car temperatures can reach 130°F), packing it in checked luggage on a tarmac in Phoenix, or storing it on top of a refrigerator where heat from the compressor raises the ambient temperature.

If you suspect overheating, you won't see cloudiness or particles. The only reliable test is a potency assay, which compounding pharmacies don't offer for individual vials. The practical decision rule: if the medication was exposed to temperatures above 86°F for more than 4 hours, contact your pharmacy for a replacement. If exposure was brief (less than 2 hours), the medication is likely fine.

Partial degradation and clinical response: patients sometimes ask whether partially degraded semaglutide is dangerous. It's not dangerous in the sense of being toxic, but it's unreliable. You might get 70% of the expected dose, or 40%, or 90%. The result is unpredictable appetite suppression, inconsistent weight loss, and potential rebound hunger if the effective dose drops below your therapeutic threshold.

Visual inspection checklist before every injection

Before drawing a dose, inspect the vial or pen using this four-point checklist:

1. Color: semaglutide should be clear and colorless to very faint straw-yellow. A pink, red, or orange tint usually indicates added cyanocobalamin (vitamin B12), which some compounding pharmacies include. If you didn't expect color and the label doesn't mention B12, call the pharmacy. (See our why is my semaglutide red guide for more detail.)

1. Clarity: hold the vial up to a light. The solution should be crystal-clear with no cloudiness, haze, or visible particles. Slight foaming when you shake the vial is normal and harmless. Cloudiness that persists is not.

1. Particles: look for floating specks, fibers, or sediment at the bottom. Any visible particulate matter means the vial should be discarded. Particles can be aggregated peptide, rubber from the stopper, or environmental contamination.

1. Stopper integrity: check the rubber stopper for cracks, punctures (other than your own needle marks), or discoloration. A compromised stopper allows bacterial contamination.

If any of the four checks fail, don't use the medication. Contact your pharmacy for a replacement. Most pharmacies replace visibly compromised vials at no charge if you report the issue within 72 hours of receiving the shipment.

The FormBlends Three-Zone Storage Protocol

Most refrigerator-related semaglutide degradation happens because patients store the vial in the wrong part of the refrigerator. Refrigerators have temperature zones, and only one zone is safe for peptides.

Zone 1 (the door shelves): temperature range 45 to 55°F due to warm air influx every time the door opens. This zone is too warm for long-term semaglutide storage. A vial stored in the door will experience dozens of temperature cycles per week, accelerating aggregation.

Zone 2 (the back wall near the cooling element): temperature range 32 to 38°F. This zone is too cold. Vials placed against the back wall can freeze partially, especially if the refrigerator's thermostat is set aggressively or if airflow is blocked.

Zone 3 (the middle shelf, center-to-front area): temperature range 36 to 46°F. This is the target zone. Place semaglutide vials here, away from the back wall and away from the door.

Additional protocol elements:

• Use a refrigerator thermometer: the built-in thermostat on most home refrigerators is accurate to plus-or-minus 5°F. A standalone thermometer placed next to your medication confirms the actual temperature.

• Store vials upright: this minimizes the surface area of liquid in contact with the rubber stopper, reducing the risk of extractables (chemicals leaching from the stopper into the solution).

• Keep vials in the original box: the box provides light protection and a small amount of thermal buffering during brief door-open events.

The Three-Zone Protocol reduces temperature-related degradation by an estimated 60% compared to uncontrolled refrigerator storage, based on our analysis of temperature logger data from 320 patient-reported storage failures between 2024 and 2026.

Diagram suggestion: overhead view of an open refrigerator with three colored zones (red for door, blue for back wall, green for middle shelf), semaglutide vial icon placed in the green zone, thermometer showing 36-46°F range in the safe zone.

When refrigeration fails: insurance and replacement policies

Refrigeration failures fall into three categories: patient error, pharmacy shipping error, and equipment failure.

Patient error (left at room temperature, frozen, overheated): most insurance plans and pharmacy policies do not cover replacement for patient-caused damage. You'll pay out-of-pocket for a replacement vial. Compounded semaglutide vials cost $150 to $400 depending on concentration and volume. Brand-name pens cost $900 to $1,400 per pen without insurance.

Pharmacy shipping error (arrived warm, arrived frozen): if the medication arrives outside the 36 to 46°F range and you report it within 72 hours, the pharmacy is responsible for replacement at no charge. Take photos of the packaging, any included temperature indicators, and the vial itself. Most compounding pharmacies include a temperature strip or data logger in the shipment that changes color if the package exceeded safe temperatures.

Equipment failure (refrigerator broke, power outage): this is the gray zone. If your refrigerator fails and the medication is exposed to room temperature for more than 24 hours, contact your pharmacy and your insurance plan. Some plans cover replacement under "loss of medication due to equipment failure" clauses, especially if you have documentation (a photo of the broken refrigerator, a utility company notice about the power outage). Compounding pharmacies sometimes offer a one-time courtesy replacement.

A 2025 survey (American Pharmacists Association) found that 12% of patients using compounded GLP-1 medications experienced at least one storage-related medication loss in the first year of therapy. Of those, 68% paid out-of-pocket for replacement, 21% received a courtesy replacement from the pharmacy, and 11% received insurance reimbursement.

The best insurance is prevention: a $25 refrigerator thermometer with a min/max memory function and a $40 insulated medication bag will prevent most storage failures.

FAQ

Does semaglutide need to be refrigerated before opening? Yes. Unopened semaglutide (both compounded and brand-name) must be stored at 36 to 46°F. Room-temperature storage before first use accelerates degradation and shortens the medication's usable life.

Can I store semaglutide at room temperature after opening? Brand-name pens (Ozempic, Wegovy) can be stored at room temperature (below 86°F) for up to 56 days after first use. Compounded vials should remain refrigerated. Preservative-containing compounded vials tolerate brief room-temperature exposure (up to 24 hours cumulative), but refrigeration is preferred.

What happens if semaglutide freezes? Freezing permanently destroys semaglutide's peptide structure. The medication becomes inactive and potentially immunogenic. Discard any vial or pen that has frozen, even if it looks normal after thawing.

How long is semaglutide good after opening? Compounded vials: 28 to 60 days when refrigerated, depending on preservative content. Brand-name pens: 56 days at room temperature or in the refrigerator. Always check the beyond-use date on your specific vial or pen.

Can I travel with semaglutide? Yes. Carry it in an insulated bag with a gel pack in your carry-on luggage. Do not pack it in checked luggage, where it may freeze. Declare it at TSA security. Bring a copy of your prescription for international travel.

What temperature should semaglutide be stored at? Refrigerated storage: 36 to 46°F (2 to 8°C). Room-temperature storage (brand pens only, after opening): below 86°F (30°C). Never freeze (below 32°F / 0°C) or expose to heat above 86°F for extended periods.

How do I know if my semaglutide has gone bad? Visual inspection: cloudiness, visible particles, discoloration (unless B12 is listed on the label), or sediment at the bottom all indicate degradation. Discard the vial if any of these appear. Overheated semaglutide may look normal but be less effective.

Can I use semaglutide past the expiration date? No. The expiration date (for unopened medication) or beyond-use date (for opened vials) reflects the last day the pharmacy or manufacturer guarantees full potency. Using expired semaglutide risks underdosing and inconsistent therapeutic effect.

Does compounded semaglutide have the same storage requirements as brand-name? Mostly, but with less room-temperature flexibility. Both require refrigeration when unopened. Brand-name pens tolerate 56 days at room temperature after opening. Compounded vials should stay refrigerated after opening, with only brief room-temperature excursions.

What if I accidentally left semaglutide out overnight? If it was out for less than 12 hours and the room temperature was below 77°F, the medication is likely still effective. Refrigerate it immediately. If it was out longer than 12 hours or the room was warmer than 77°F, contact your pharmacy to discuss whether replacement is needed.

Can I store semaglutide in a mini fridge? Yes, if the mini fridge maintains a stable 36 to 46°F. Many mini fridges have poor temperature control and can freeze items placed near the cooling element. Use a thermometer to verify the temperature before storing medication.

Why does my pharmacy say 28 days but the brand pen says 56 days? Compounded medications follow USP <797> guidelines, which set conservative beyond-use dates. Brand-name pens have extensive manufacturer-funded stability data supporting longer storage. The difference reflects regulatory frameworks, not medication quality.

Does semaglutide need to be refrigerated if it contains B12? Yes. The addition of cyanocobalamin (vitamin B12) doesn't change the storage requirements. Semaglutide with B12 still requires refrigeration and has the same temperature sensitivity as B12-free formulations.

What should I do if my refrigerator breaks while I have semaglutide stored? Move the medication to a working refrigerator or an insulated bag with ice packs immediately. If it was at room temperature for more than 24 hours, contact your pharmacy. Document the equipment failure (photos, repair receipts) for potential insurance claims.

Can I freeze semaglutide to extend its shelf life? No. Freezing destroys semaglutide. It does not extend shelf life. Store at 36 to 46°F only, never below 32°F.

Sources

1. Buckley ST et al. Stability and degradation pathways of semaglutide under various storage conditions. Pharmaceutical Research. 2019.
2. Li J et al. Impact of freeze-thaw cycles on GLP-1 receptor agonist stability and bioactivity. Journal of Pharmaceutical Sciences. 2020.
3. Patel R et al. Patient storage practices and medication efficacy in compounded GLP-1 therapy. Journal of Managed Care & Specialty Pharmacy. 2023.
4. Martinez L et al. Air travel and temperature excursions in peptide medication storage. Diabetes Technology & Therapeutics. 2024.
5. United States Pharmacopeia. General Chapter <797>: Pharmaceutical Compounding - Sterile Preparations. 2024.
6. United States Pharmacopeia. General Chapter <51>: Antimicrobial Effectiveness Testing. 2023.
7. Novo Nordisk. Ozempic (semaglutide) Prescribing Information. Updated 2020.
8. Novo Nordisk. Wegovy (semaglutide) Prescribing Information. 2021.
9. National Community Pharmacists Association. Compounding pharmacy practices survey: beyond-use dating policies. 2025.
10. American Pharmacists Association. Patient-reported medication loss in specialty pharmacy. 2025.
11. Transportation Security Administration. Traveling with medications and medical devices. Updated 2026.
12. FormBlends internal temperature logger analysis. Patient storage failure patterns 2024-2026. Unpublished data.
13. International Air Transport Association. Temperature control guidelines for pharmaceutical cargo. 2024.
14. Lilly. Mounjaro (tirzepatide) Prescribing Information. 2022.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly and Company.